The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 04, 2020
Filed:
Aug. 01, 2014
Applicant:
Eutropics Pharmaceuticals, Inc., Cambridge, MA (US);
Inventor:
Michael H. Cardone, Dorchester, MA (US);
Assignee:
Eutropics Pharmaceuticals, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 31/00 (2006.01); G01N 33/53 (2006.01); G01N 33/574 (2006.01); C07K 16/40 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57496 (2013.01); C07K 16/40 (2013.01); G01N 33/574 (2013.01); G01N 33/57488 (2013.01); C07K 2317/622 (2013.01); G01N 2333/96466 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention relates to methods of determining cancer cell sensitivity to treatment by using antibodies that specifically bind to and detect the presence of a Bcl-2 heterodimer protein, or a caspase and an inhibitor of caspase-IAP heterodimer protein in the cell. The methods provide a predictive tool to identify patients likely to respond to drugs that perturb heterodimer binding and induce apoptosis in a cancer cell. The invention also provides a method of predicting therapeutic efficacy in a cancer patient.